| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00871546 Details | 2015-08-07 Interventional | 2 | 8 | Alemtuzumab Bortezomib Leukemia Leukemia, Lymph… Leukemia, Lymph… Lymphoma Lymphoma, Mantl… | - - | |||
| NCT01798836 Details | 2015-08-06 Interventional | 2/3 | [2 Refs] | 17 | Estradiol Estradiol 17 be… Estradiol 3-ben… Polyestradiol p… Prolactin Relea… Infertility | Obtained results were not good. Protocol was proved ineffective. - | ||
| NCT01539018 Details | 2015-08-05 Interventional | 2 | 77 | Sorafenib Tegafur Carcinoma, Hepa… Advanced Hepato… | After interim results data showed no evidence of a difference between both groups - | |||
| NCT01714648 Details | 2015-08-04 Interventional | 4 | 6 | Triptorelin Pam… Ovarian Hyperst… Syndrome | Terminated: recruiting or enrolling participants has halted prematurely and will not resume;
participants are no longer being examined or treated - | |||
| NCT00279461 Details | 2015-08-04 Interventional | 2 | 0 | Cholecalciferol Ergocalciferols Vitamin D Vitamins Arthritis Arthritis, Rheu… Immune System D… Vitamin D Defic… | Dr. Levy terminated from IU in December 2009. Indiana University has no record that this study
was initiated prior to his termination. - | |||
| NCT01467492 Details | 2015-08-03 Interventional | 4 | 121 | Interferon alph… Interferon-alph… Interferons Peginterferon a… Ribavirin Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… | It was decided by Sponsor on 13 January 2014 to terminate study early at primary efficacy
endpoint as part of a decision to modify drug development plan. It was decided by Sponsor on 13 January 2014 to terminate the study early as part of a decision to modify the drug development plan. Eligible participants completed virologic follow-up after termination. | |||
| NCT00574483 Details | 2015-08-03 Interventional | 2 | 0 | Quinacrine Carcinoma Carcinoma, Rena… Renal Cell Carc… | reevaluation of compound development - | |||
| NCT01413581 Details | 2015-07-30 Interventional | 3 | 415 | Bile Acids and … Premature Birth Prevention of G… | Primary endpoint showed no stat significant difference. FU > M12 terminated. - | |||
| NCT01058642 Details | 2015-07-30 Interventional | 2 | 41 | Pregabalin Neuralgia Neuralgia, Post… Postherpetic Ne… | - On the basis of the interim analysis, the results indicated that ADL5747 did not show sufficient efficacy to continue the study; therefore, formal and final efficacy analyses were not generated for this study. | |||
| NCT00933023 Details | 2015-07-30 Interventional | 4 | 0 | Betamethasone Hydrocortisone Phimosis | Patient numbers estimated to be too low to complete the trial in less than 10 years - | |||
| NCT00799201 Details | 2015-07-29 Interventional | 4 | 3 | Naloxone Constipation Analgesia | Naloxone became unavailable due to manufacturing shortatges requiring the study to be
terminated. - | |||
| NCT01674283 Details | 2015-07-28 Interventional | 4 | 0 | Glucagon Women With Fert… | Uterine contractility not possible to visualize with our ultrasound machines - | |||
| NCT01638988 Details | 2015-07-28 Interventional | 3 | 0 | Clomiphene Enclomiphene Metformin Zuclomiphene Infertility Insulin Resista… Polycystic Ovar… Syndrome | Previous studies have been done regarding same condition - | |||
| NCT00274651 Details | 2015-07-28 Interventional | 2 | 53 | Belinostat Lymphoma Lymphoma, Non-H… Lymphoma, T-Cel… Lymphoma, T-Cel… Lymphoma, T-Cel… Cutaneous T-Cel… Non-Hodgkin's L… Peripheral T-Ce… | Enrollment stopped prior to reaching expected number of patients, study had accumulated
sufficient data to allow a registration study in PTCL (PXD101-CLN-19) - | |||
| NCT00245453 Details | 2015-07-28 Interventional | 4 | 0 | Azithromycin Clarithromycin Telithromycin Bronchitis Bronchitis, Chr… Pneumonia Pneumonia, Bact… Respiratory Tra… | Terminated by sponsor - | |||
| NCT01527019 Details | 2015-07-27 Interventional | 3 | 0 | Cephalosporins Norfloxacin Cystitis | the company suspended the persecution of this combination - | |||
| NCT01471925 Details | 2015-07-27 Interventional | 3 | 0 | Esomeprazole Esophagitis, Pe… Gastroesophagea… Gastroesophagea… | Change company strategy - | |||
| NCT01345084 Details | 2015-07-27 Interventional | 3 | 0 | Nimotuzumab Carcinoma Head and Neck C… | change company strategy - | |||
| NCT01710462 Details | 2015-07-24 Interventional | 3 | 0 | Domperidone Pantoprazole Esophagitis, Pe… Gastroesophagea… Gastroesophagea… | Change of company's strategy - | |||
| NCT01420523 2011-002483-24 Details | 2015-07-24 Interventional | 2 | 48 | Maraviroc Raltegravir Pot… Acquired Immuno… HIV Infections Human Immunodef… Lipohypertrophy | - - |